A major goal of systems biology is to build predictive computational models of cellular metabolism. Availability of complete genome sequences and wealth of legacy biochemical information has led to the reconstruction of genome-scale metabolic networks in the last 15 years for several organisms across the three domains of life. Due to paucity of information on kinetic parameters associated with metabolic reactions, the constraint-based modelling approach, flux balance analysis (FBA), has proved to be a vital alternative to investigate the capabilities of reconstructed metabolic networks. In parallel, advent of high-throughput technologies has led to the generation of massive amounts of omics data on transcriptional regulation comprising mRNA transcript levels and genome-wide binding profile of transcriptional regulators. A frontier area in metabolic systems biology has been the development of methods to integrate the available transcriptional regulatory information into constraint-based models of reconstructed metabolic networks in order to increase the predictive capabilities of computational models and understand the regulation of cellular metabolism. Here, we review the existing methods to integrate transcriptional regulatory information into constraintbased models of metabolic networks.
Introduction
Extensive research by biochemists in the last century has resulted in the chemical characterization of thousands of biochemical reactions (Kanehisa and Goto, 2000; Chang et al., 2009) . Towards the end of 20 th century, complete genome sequences became available for the first time (Fleischmann et al., 1995; Tomb et al., 1997) . In the postgenomic era, a focus in systems biology has been the reconstruction of genome-scale metabolic networks using the annotated sequences along with available biochemical, genetic and phenotypic information for organisms (Edwards et al., 2001; Forster et al., 2003; Duarte et al., 2007; Feist et al., 2009; Thiele and Palsson, 2010; Thiele et al., 2013) .
In the last 15 years, considerable effort has led to the reconstruction of manually curated and high quality genome-scale metabolic networks for more than 50 organisms including humans (Durot et al., 2009; Feist et al., 2009; Thiele and Palsson, 2010) . However, the current pace of manual reconstruction of high quality genome-scale metabolic networks lags far behind the sequencing effort, and thus, automated methods have also been developed to aid and accelerate the speed of metabolic network reconstruction process (Henry et al., 2010; Schellenberger et al., 2011; Agren et al., 2013) . Several studies have demonstrated the utility of these genome-scale metabolic reconstructions for biological discovery and hypothesis generation (Feist and Palsson, 2008; Oberhardt et al., 2009 ). Current paucity of information on relevant parameters such as rate constants, enzyme concentrations and metabolite concentrations for most reactions renders kinetic modelling of genome-scale metabolic networks infeasible. In the face of inadequate kinetic information, the constraint-based modelling method, flux balance analysis (FBA), has proved to be a vital alternative to study the capabilities of genome-scale metabolic constraint-based FBA models of genome-scale metabolic reconstructions can lead to more accurate models. However, there are several challenges in integration of omics data stemming from the inherent experimental and biological noise in such datasets (Quackenbush, 2004) . Nonetheless, several constraint-based methods have been developed to integrate experimental data, especially on transcriptional regulation and gene expression, within the FBA framework to build improved models (Åkesson et al., 2004; Covert et al., 2004; Becker and Palsson, 2008; Blazier and Papin, 2012; . In this review, we discuss the existing methods to integrate regulatory information into constraint-based FBA models by broadly classifying them into three different approaches (Covert et al., 2001; Åkesson et al., 2004; Covert et al., 2004; Becker and Palsson, 2008; Chandrasekaran and Price, 2010; Blazier and Papin, 2012; Kim and Reed, 2014) . Such methods have already proven successful in building context-specific metabolic models for human tissues and predicting novel drug targets in pathogens (Becker and Palsson, 2008; Folger et al., 2011; Bordbar et al., 2012; Collins et al., 2012) .
The review is organized as follows. In the second section, we describe the constraint-based FBA framework. In the third section, we discuss existing methods to integrate omics data within the FBA framework as additional flux constraints to build context-specific metabolic models. In the fourth section, we describe the reconstruction and analysis of integrated regulatory-metabolic models where Boolean transcriptional regulatory networks (TRNs) are incorporated within the FBA framework. In the fifth section, we discuss the need for automated methods to integrate information on regulatory network architecture and expression measurements within metabolic networks to reconstruct integrated regulatory-metabolic models. Note that previous reviews in this area only emphasize on methods that are descriptive in nature which are presented in section 3 of this review. In comparison to previous reviews, we here provide a much more comprehensive overview of the area by also describing in detail the methods which are predictive rather than just descriptive in nature in sections 4 and 5 of this review.
Flux balance analysis
Flux balance analysis (FBA) is a constraint-based modelling approach that is widely used to investigate the capabilities of available genome-scale metabolic networks (Varma and Palsson, 1994; Kauffman et al., 2003; Price et al., 2004; Orth et al., 2010;  in an organism along with the stoichiometric coefficients of involved metabolites to predict the fluxes of all reactions in the metabolic network. Such biochemical information is contained within available organism-specific genome-scale metabolic reconstructions. For any organism, the genome-scale metabolic reconstruction contains information on all known metabolic reactions and genes encoding enzymes catalysing different reactions in the network (Palsson, 2006) (Fig. 1A) . Notably, genome-scale metabolic reconstructions for most organisms also include reactions for transport of metabolites across the cell boundary, and a pseudo-reaction capturing the production of biomass in terms of their precursor metabolites (Fig. 1A ).
In the FBA framework, the list of reactions along with the stoichiometric coefficients of involved metabolites in a network reconstruction is mathematically represented in the form of a stoichiometric matrix 
‫܁‬
give the stoichiometric coefficients of metabolites participating in a particular reaction, where negative coefficients signify consumption of a metabolite, positive coefficients signify production of a metabolite, and zero coefficients signify no participation of a metabolite in the reaction (Fig. 1B) . These stoichiometric coefficients of metabolites in various reactions impose constraints on the flow of metabolites in the network (Heinrich and Schuster, 1996; Schilling et al., 1999; Palsson, 2006) .
Subsequently, the method capitalizes on these stoichiometric constraints and assumes steady state to predict the fluxes of all reactions in the network.
In any metabolic steady state, different metabolites attain a mass balance wherein the rate of production of each metabolite is equal to its rate of consumption, and this leads to the system of mass balance equations given by:
where ‫ܞ‬ is the vector of fluxes through all reactions in the network (Fig. 1B ). For each metabolite in the network, Eq. 1 gives a linear equation relating fluxes of various reactions in which the metabolite participates ( Fig. 1B) . Since, the number of metabolites is much less than the number of reactions in genome-scale metabolic networks of most organisms, the number of linear equations is much less than the number of reaction fluxes (unknowns) to be determined. Thus, Eq. 1 typically leads to an under-determined system of linear equations, and a large solution space of allowable fluxes for genome-scale metabolic networks ( Fig. 1B,C) .
The size of the allowable space can also be reduced by incorporating additional constraints on reaction fluxes. Firstly, certain reactions in the metabolic network are irreversible under physiological conditions, and such thermodynamic constraints (Beard et al., 2002; Orth et al., 2010) can be used to constrain the flux of irreversible reactions.
Secondly, the activity of specific enzymes may limit the flux through certain reactions.
Thirdly, the availability of nutrients in the growth medium can be used to constrain the fluxes of transport reactions. Note that unlike stoichiometric or mass-balance constraints, these additional constraints represent bounds on reaction fluxes in the metabolic network ( Fig. 1B) .
Since stoichiometric and additional constraints lead to an under-determined system with a large space of possible solutions, FBA uses linear programming (LP) to find a particular solution within the allowable solution space that either maximizes or minimizes a certain biologically relevant linear objective function ܼ (Watson, 1984; Fell and Small, 1986; Varma and Palsson, 1994) (Fig. 1C) . Some examples of biologically relevant objective functions that have been explored using FBA include maximization of biomass production, maximization of ATP production and minimization of redox potential (Schuetz et al., 2007) . However, maximization of biomass production (Feist and Palsson, 2010) is usually chosen as the objective function in FBA. The LP formulation of FBA can be written as:
involved in microbial pathogenesis, identification of drug targets, understanding reductive evolution in microbes and generating tissue-specific metabolic models for normal and cancerous tissues (Burgard et al., 2003; Pal et al., 2006; Becker and Palsson, 2008; Gianchandani et al., 2010; Folger et al., 2011; Bordbar et al., 2012; Collins et al., 2012) .
Integration of transcriptomic profiles to build context-specific metabolic models
FBA predicts the fluxes of reactions and the biomass production rate without accounting for the regulatory constraints that are crucial in determining the presence and activity of enzymes in an environmental condition (Orth et al., 2010) . This omission of regulatory constraints is an important limitation of FBA (Covert and Palsson, 2002 Palsson, , 2003 Åkesson et al., 2004) and can partly explain incorrect predictions by this method on gene essentiality (Covert et al., 2004) and gene interactions (Szappanos et al., 2011) . The metabolic state of a cell in a given condition is governed by the expression of metabolic genes encoding enzymes. Thus, gene expression measurements obtained from microarrays or RNA-sequencing (RNA-seq) provide vital information on the state of the regulatory network and its influence on the metabolic network. With drastic reduction in cost of microarrays and RNA-seq, these high-throughput technologies are being increasingly used to generate abundant information on the expression of genes for several organisms under varied environmental conditions. Such data can be readily exploited to understand the condition-specific activity and regulation of metabolism.
Towards this goal, several constraint-based methods have been developed in the last few years to integrate gene expression data within the FBA framework to generate contextspecific metabolic models (Blazier and Papin, 2012; Lewis et al., 2012; Hyduke et al., 2013; Kim and Reed, 2014; Machado and Herrgård, 2014; Saha et al., 2014; Imam et al., 2015) . The available methods can be broadly classified into three categories (Estévez and Nikoloski, 2014) , namely, switch-and valve-based methods that use omics data to determine active and inactive set of genes in a given condition, methods that generate context-specific metabolic models without the need for a predefined biological objective function, and methods based on iterative removal of inferrred non-functional reactions to build tissue-specific metabolic models.
In the first category of methods, transcriptomic data is used to determine the set of active and inactive (absent) genes in a given condition (Fig. 2 ). Next, the information on active and inactive genes is used to set bounds on reaction fluxes catalysed by associated gene products (enzymes) within the FBA framework before computing the flux distribution and biomass rate. The treatment of bounds on reaction fluxes catalysed by active and inactive enzymes varies between different methods in this category, and this leads to a further classification into two sub-categories (Fig. 2 ). In the sub-category of switch-based methods, the upper bound for the maximum flux through reactions catalysed by active enzymes is left unconstrained while those for reactions catalysed by inactive enzymes is set to zero before computing the flux distribution using FBA (Fig. 2) . In the sub-category of valve-based methods, the upper bound for the maximum flux through reactions catalysed by enzymes is set proportional to the normalized expression of the associated genes before computing the flux distribution using FBA (Fig. 2) . Basically, these methods are all based on the assumption that gene expression is correlated with reaction fluxes which may not necessarily hold (Gygi et al., 1999; ter Kuile and Westerhoff, 2001; Yang et al., 2002) . Moreover, omics measurements suffer from a lack of sensitivity leading to false negatives in the identification of active and inactive genes. Notably, switching off flux through reactions catalysed by inactive genes which are false negatives due to experimental noise, may render the FBA predictions inconsistent with the biological objective or required metabolic function. Thus, the first category of methods also have the option to selectively re-enable flux through some reactions catalysed by inactive enzymes, to overcome any potential inconsistent FBA predictions with the required metabolic function (Becker and . (GIMME), which is widely used to build context-specific metabolic models. Unlike Akesson et al, GIMME semi-automatically assesses the inactive gene set for potential false negatives, and re-enables any reaction flux associated with such false negatives. In addition, GIMME has the advantage of reporting an inconsistency score between the gene expression data and the predicted flux distribution. Although the methods in this category were initially developed to integrate transcriptomic data, overtime these methods (Becker and Schmidt et al., 2013) have also been utilized to incorporate other types of omics data, such as proteomics and metabolomics, within the FBA framework.
In The third category includes methods that were envisaged to build mammalian tissue-specific metabolic models. These methods integrate diverse omics data and literature based annotations to define two sets of reactions, core and non-core, for a specific tissue type. Reactions in the core set are highly likely to be functional while those in the non-core set are unlikely to be functional in the tissue under consideration. After defining the core and non-core set of reactions for a given tissue, these methods attempt to iteratively remove each non-core reaction subject to preserving the functionality of the core reaction set, and this leads to a tissue-specific metabolic model from a generic metabolic model. Some of the methods which fall into this third category include the model building algorithm (MBA) (Jerby et al., 2010) , the metabolic context-specificity assessed by deterministic reaction evaluation (mCADRE) (Wang et al., 2012) , fast reconstruction of compact context-specific metabolic network model (FASTCORE) (Vlassis et al., 2014) and cost optimization reaction dependency assessment (CORDA) (Schultz and Qutub, 2016) .
We emphasize that some of the proposed methods to integrate omics data within the FBA framework, such as metabolic adjustment by differential expression (MADE) (Jensen and Papin, 2011) and temporal expression-based analysis of metabolites (TEAM) (Collins et al., 2012) , cannot be clearly assigned to any of the above mentioned three categories. MADE requires expression data from two or more successive conditions, such as a temporal expression profile, to determine differential expression of genes. Based on statistically significant changes in expression of genes between successive conditions, MADE infers highly and lowly expressed reactions for a sequence of conditions without the need for a predefined threshold. Finally, MADE solves a single MILP problem to generate context-specific metabolic model that best recapitulates the expression dynamics across successive conditions. On the other hand, TEAM is a fusion method based on dynamic FBA (Mahadevan et al., 2002) and GIMME to integrate temporal gene expression data within the FBA framework to predict time course flux distributions. In Supplementary Table 1 , we list all the different methods developed so far to integrate omics data within the FBA framework.
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Incorporation of Boolean transcriptional regulatory networks to build integrated regulatory-metabolic models
In the previous section, we discussed several existing methods to integrate multiomics data as additional flux constraints within the FBA framework to understand the condition-specific regulation of metabolism. Note that such methods are inherently descriptive rather than predictive in nature (Covert et al., 2004; Chandrasekaran and Price, 2010) . That is, such methods are only able to describe the regulation of metabolism in conditions with available omics data but cannot predict in conditions lacking omics data.
Moreover, such methods do not explicitly incorporate available information on transcriptional regulatory interactions within the FBA framework, and thus, their Integrated regulatory-metabolic models (Covert et al., 2004; Herrgard et al., 2006; Goelzer et al., 2008) have been manually reconstructed for some model organisms by unifying Boolean models of TRNs with FBA models of metabolic networks (Fig. 3) (Goelzer et al., 2008) and S. cerevisiae (Herrgard et al., 2006) . Note that these integrated regulatory-metabolic models can also predict the metabolic phenotype of TF perturbations. where the present regulatory state is also influenced by the metabolic state in the previous time interval. Next, rFBA uses the predicted activity of genes in the current time interval to constrain the flux of associated reactions within the FBA framework and compute the steady state flux distribution or metabolic state for the current interval (Fig. 3) . Note that rFBA also predicts the temporal dynamics of concentration of external substrates available for uptake, concentration of secreted by-products and cell growth. It has been shown that the application of rFBA to the integrated regulatory-metabolic model iMC1010 for E. coli can significantly increase the ability to predict knockout phenotypes across diverse environmental conditions (Covert et al., 2004) .
One limitation of rFBA is that it arbitrarily chooses one optimal flux distribution as the metabolic state of the integrated model from a space of alternate optimal flux distributions at each time interval, and steady-state regulatory flux balance analysis (SR-FBA) (Shlomi et al., 2007) is a MILP based method which tries to overcome this limitation.
Another limitation of using rFBA is that constraint-based methods do not predict the kinetics of internal metabolite concentrations which is important to understand the allosteric regulation of metabolism. On the other hand, detailed kinetic models (Chassagnole et al., 2002; Bettenbrock et al., 2007) can properly account for allosteric regulation but such models are limited to specific metabolic pathways due to paucity of kinetic data. For example, such a detailed kinetic model (Bettenbrock et al., 2007) with less than 50 reactions has been built to study carbon catabolite repression in E. coli.
Covert et al. (Covert et al., 2008) have developed a hybrid framework, integrated FBA (iFBA), which combines rFBA for genome-scale networks and kinetic models for smaller well characterized pathways to improve the predictive ability of integrated models.
Automated reconstruction of integrated regulatory-metabolic models
In the previous section, we reviewed manually reconstructed integrated regulatorymetabolic models where transcriptional regulatory interactions is represented as Boolean rules. However, manual reconstruction of Boolean models of TRNs from available information on interactions between TFs and their regulated genes can be a slow and tedious process. Firstly, it is extremely difficult to infer a single well-defined set of Boolean logical functions for genes in the TRN based on experimentally determined expression states in different conditions (Henry et al., 2013) . Secondly, the Boolean approximation where each gene can have only two states, active or inactive, is an over-simplified view of the system that is inadequate to capture the complex regulation of enzymes in many situations. Thus, Boolean network based integrated regulatory-metabolic models have been manually reconstructed for only three organisms (Covert et al., 2004; Herrgard et al., 2006; Goelzer et al., 2008) to date.
On the other hand, large-scale sequencing projects such as ENCODE and modENCODE (Gerstein et al., 2010; Gerstein et al., 2012) have generated vast amounts of regulatory information for humans and model organisms, mainly, in the form of RNA-seq and ChIP-seq data in diverse biological contexts.
Moreover, with the rapid fall in the cost of sequencing, experimental biologists are routinely generating RNA-seq and ChIP-seq data for their pet organisms. RNA-seq data gives information on mRNA abundances or gene expression in a given condition and ChIP-seq data on genome-wide binding profile for TFs or transcriptional regulatory interactions. Combination of ChIP-seq and RNA-seq data can be used to reconstruct the TRN of an organism, and thus, such information can be incorporated within genome-scale metabolic reconstructions to build integrated regulatory-metabolic models (Fig. 4) . Given the slow pace of manual reconstruction process, automated approaches combining information on regulatory network architecture and gene expression data are best suited to address the challenge of turning the deluge of high-throughput data into predictive systems biology models.
In this direction, probabilistic regulation of metabolism (PROM) (Chandrasekaran and Price, 2010) , is the only automated method to date. PROM combines information on TRN architecture and gene expression data within the FBA framework to build an integrated model. In PROM, the set of interactions between TFs and target genes in the TRN is used along with gene expression data across multiple conditions to predict the likelihood of the expression of a target gene given the expression state of the controlling TF. In PROM, such probabilities are then used to constrain the maximum allowable flux through reactions associated with the target genes before computing the flux distribution using FBA. Thus, PROM can predict the consequences of TF perturbations unlike methods in the first approach. Also, the prediction accuracy achieved by PROM was similar to the manually reconstructed integrated regulatory-metabolic model of E. coli.
Nevertheless, the existing methods including PROM have limitations that provide scope for future improvements. Firstly, the existing automated method does not make use of information on environment-dependent or condition-specific regulation. Secondly, the existing methods are designed to integrate high-confidence regulatory interactions from manually reconstructed TRNs. In contrast, regulatory interactions inferred from ChIP-seq data are likely to be very noisy, and future methods should address this challenge. Thirdly, existing methods do not account for available information on feedback regulation of enzymes by intracellular metabolites. Addressing this challenge may require transition to hybrid models where a combination of constraint-based and kinetic approaches will be necessary to simulate metabolic networks (Covert et al., 2008) . Finally, the existing automated method to build integrated regulatory-metabolic model is static in time and not designed to incorporate temporal expression data. We expect future automated methods will overcome some of the above-mentioned limitations.
Conclusion
In this review, we have presented an overview of three different approaches for integrating available regulatory information within constraint-based FBA models of genome-scale metabolic reconstructions. Previous reviews (Blazier and Papin, 2012; Hyduke et al., 2013; Estévez and Nikoloski, 2014) in this area have largely focused on the first approach where considerable research has led to several methods where omics data is directly integrated within the FBA framework as additional flux constraints ( Supplementary Table 1 ). Such methods including GIMME (Becker and ,
iMAT , INIT (Agren et al., 2012) and MBA (Jerby et al., 2010) have been successful in building context-and tissue-specific metabolic models. Notably, the methods in the first approach are rather descriptive than predictive as they do not explicitly incorporate the available information on regulatory interactions in the TRN (Chandrasekaran and Price, 2010) . In this review, we also focus on two other approaches to build integrated regulatory-metabolic models. First such approach involves manual reconstruction of integrated regulatory-metabolic models where transcriptional regulatory information is represented as Boolean networks (Covert et al., 2004; Herrgard et al., 2006; Goelzer et al., 2008) . Such Boolean based integrated regulatory-metabolic models can be studied using rFBA and allied approaches (Shlomi et al., 2007; Samal and Jain, 2008) .
Since manual reconstruction of integrated models is a painstaking and time consuming process, the need of the hour is to develop automated methods to incorporate the flood of next generation sequencing data such as RNA-seq and ChIP-seq within genome-scale metabolic reconstructions to build integrated regulatory-metabolic models. Such automated methods will eventually enable the systems biology community to reconstruct whole-scale models (Karr et al., 2012) for several organisms.
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